Provided is a pharmaceutical preparation containing a calcium antagonist and an angiotensin II receptor antagonist as active ingredients, and containing 5 mass% or more of a disintegrant, the pharmaceutical preparation being characterized in that at least the calcium antagonist has the form of a solid dispersion. The pharmaceutical preparation improves the storage stability of the angiotensin II receptor antagonist. The pharmaceutical preparation has an elution profile similar to those of commercially available calcium antagonist preparations and commercially available angiotensin II receptor antagonist preparations.
